News Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Investor Alerts

Year All Years 2019 2018 2017 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Sep 13, 2019

  Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
• Sep 5, 2019

  Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
• Sep 4, 2019

  Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
• Aug 8, 2019

  /C O R R E C T I O N -- Achieve Life Sciences, Inc./
• Jul 30, 2019

  Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
• Jul 23, 2019

  Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation
• Jun 21, 2019

  Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
• Jun 11, 2019

  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
• Jun 3, 2019

  Achieve Receives $4.2 Million from Exercise of Warrants
• May 30, 2019

  Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline

Show 5102550100 per page